Brief: Index Pharmaceuticals Enrols First Patient In Late-Stage Study Of Cobitolimod

Flerie AB

24/11/2021 12:08

Nov 24 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS ENROLS FIRST PATIENT IN THE PHASE
III
STUDY CONCLUDE WITH COBITOLIMOD IN ULCERATIVE COLITIS

Source text for Eikon:  ID:nPn2P7Hd0a 
Further company coverage:  INDEX.ST 

 ((Reuters.Briefs@thomsonreuters.com;))